Asia Strategy — Pharmaceuticals
Asia Strategy — Pharmaceuticals
Context: Asia Growth Strategy
- Which countries to contest
- Size and growth of generics markets including
- South Korea, Indonesia, Taiwan, Thailand, Philippines
- Versus country risk, distribution infrastructure, reimbursement and local competitor power
- Size and growth of generics markets including
- Where to focus – therapy segments
- Assessment of target segments ranging from
- Asthma/COPD, Cardiovascular, Diabetes, Dermatological and GU system (ATC codes)
- Competitiveness of existing compounds versus in-licensing of new compounds
- Assessment of target segments ranging from
- Detailed action plans for
- Pricing and promotion
- Additional sales headcount
- Direct or partner distributor
Results delivered
$25 million incremental revenue.
